Acute nonlymphocytic leukemia following etoposide and cisplatin combination chemotherapy for advanced non-small-cell carcinoma of the lung
Authors:
Open Access
- 1 November 1987
- journal article
- Published by American Society of Hematology in Blood
- Vol. 70 (5) , 1412-1417
Abstract
Combination chemotherapy is frequently used in the therapy of advanced non-small-cell lung cancer (NSCLC), but late complications are rarely recognized because of the short survival of most patients. Of 119 patients with advanced NSCLC treated with cisplatin and other drugs, four patients developed acute nonlymphocytic leukemia (ANLL). All four patients received etoposide and cisplatin with or without vindesine. Leukemia was diagnosed at 13, 19, 28, and 35 months after start of treatment. Three patients had morphologic and/or cytogenetic features of acute leukemia with significant monoblastic involvement; the fourth patient had trilineage dysplasia and cytogenetic abnormalities more commonly associated with therapy-related leukemia. Detailed analysis of the subgroup who survived longer than 1 year (24 patients) suggests that high cumulative doses of etoposide are leukemogenic; the median etoposide dose was 6,795 mg/m2 (first year only) in the four leukemic patients compared with 3,025 mg/m2 in the 20 nonleukemic patients (P less than .01). The rate of ANLL was 0.30 per person-year after the first year (95% confidence limits 0.11 to 0.90), with a cumulative risk of 15% +/- 11% at 2 years, and 44% +/- 24% at 2.5 years. We conclude that high doses of etoposide are potentially leukemogenic, and can induce a syndrome with features of acute monoblastic leukemia de novo that is distinct from other secondary leukemias.Keywords
This publication has 7 references indexed in Scilit:
- Long-term survivors in metastatic non-small-cell lung cancer: an Eastern Cooperative Oncology Group Study.Journal of Clinical Oncology, 1986
- In vivo stimulation by antitumor drugs of the topoisomerase II induced cleavage sites in c-myc protooncogeneBiochemical and Biophysical Research Communications, 1986
- Clinical and cytogenetic correlations in 63 patients with therapy-related myelodysplastic syndromes and acute nonlymphocytic leukemia: further evidence for characteristic abnormalities of chromosomes no. 5 and 7.Journal of Clinical Oncology, 1986
- Risk of Acute Nonlymphocytic Leukemia and Preleukemia in Patients Treated with Cyclophosphamide for Non-Hodgkin's LymphomasAnnals of Internal Medicine, 1985
- Therapy-related acute myeloid leukemia and myelodysplastic syndrome: a clinical and morphologic study of 65 casesBlood, 1985
- Morphologic and Cytochemical Observations on the Overt Leukemic Phase of Therapy-related LeukemiaAmerican Journal of Clinical Pathology, 1983
- A possible specific chromosome marker for monocytic leukemia: Three more patients with t(9;11)(p22;q24) and another with t(11;17)(q24;q21), each with acute monoblastic leukemiaCancer Genetics and Cytogenetics, 1983